G. Aulagner

Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial

Laurent Kodjikian, Eric H. Souied, G. Mimoun et al. · Ophthalmology · 2013 · 253 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

Nathalie Bleyzac, G Souillet, P Magron et al. · Bone Marrow Transplantation · 2001 · 142 citations

Medicine, Pharmacokinetics, Pharmacology +17

The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma

F. Bernard-Arnoux, Michel Lamure, François Ducray et al. · Neuro-Oncology · 2016 · 112 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Direct costs associated with the management of progressive early onset scoliosis: Estimations based on gold standard technique or with magnetically controlled growing rods

C. Charroin, Kariman Abelin-Genevois, V. Cunin et al. · Orthopaedics & Traumatology Surgery & Research · 2014 · 62 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors

Paul J. Martin, Nathalie Bleyzac, G Souillet et al. · Bone Marrow Transplantation · 2003 · 52 citations

Medicine, Hematology, Immunology +17